In this paper we performed an updated literature review on frequency, risk factors, and underlying mechanisms of COVID-19 vaccine-related allergies by searching MEDLINE and Google Scholar databases. We also conducted a qualitative search on VigiBase and EudraVigilance databases to identify reports of...
Safety of the Novavax COVID-19 vaccine was assessed in several clinical studies. Local and systemic events were more common with the vaccine compared with placebo; such events increased in frequency and severity following the second dose.The most frequently reported solicited local adverse reaction ...
Governments all around the world started vaccination campaigns and billions of vaccine doses were administered globally including Pakistan. Although the vaccines were proven to be safe in clinical trials, in real world settings there were various adverse effects reported with the vaccines by many ...
The milestones of COVID-19 vaccine development. With the maturity of vaccine platforms, more and more COVID-19 vaccines have entered clinical trials and been approved for emergency use in many countries. However, the appearance of VOCs has brought great challenges to existing COVID-19 vaccines. ...
Altaş and Sezerol BMC Infectious Diseases (2024) 24:570 https://doi.org/10.1186/s12879-024-09460-4 BMC Infectious Diseases RESEARCH Open Access Frequency of SARS-COV-2 infection and COVID-19 vaccine uptake and protection among Syrian refugees COVID-19 Vaccine among Syrian Refugees Zeynep ...
Kamala Harris Says Trump Not Credible on Possible COVID-19 Vaccine More Reuters FILE PHOTO: Democratic U.S. vice presidential nominee Kamala Harris delivers a campaign speech in Washington, U.S., August 27, 2020, hours before the conclusion of the Republican National Convention...
able pediatric cohort with vaccine-associated myocardi-tis in the United States, 88% of the patients fulfilled the Fig. 3 Microinfarction in COVID-19 infection. Patterns of LGE (in brackets the features of each): (A) Infarct (bright, subendocardial, territorial); B Non-ischemic (mid ...
The 2024- 2025 COVID-19 vaccine is particularly recommended for people 65 and older who are at high risk for severe COVID-19, living in a long-term care facility, are pregnant/breastfeeding or have never received a COVID-19 vaccine. Immunization also lowers the risk of long CO...
Tables 1 through 6 present the frequency and severity of solicited local and systemic reactions, respectively, within 7 days following each dose of Pfizer-BioNTech COVID 19 Vaccine and placebo. Participants 16 Years of Age and Older At the time of the analysis of Study 2 for the EUA, 37,...
COVID-19 fell to the fourth-leading primary cause of death in the U.S. last year, according to a new report from the Centers for Disease Control and Prevention. SEE: Latest Coronavirus and Vaccine News The coronavirus came in behind heart disease, cancer and unintent...